EMEIS SA (EMEIS.PA) Stock Fundamental Analysis
EPA:EMEIS - Euronext Paris - Matif - FR001400NLM4 - Common Stock - Currency: EUR
We assign a fundamental rating of 1 out of 10 to EMEIS. EMEIS was compared to 29 industry peers in the Health Care Providers & Services industry. EMEIS may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, EMEIS is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
EMEIS had negative earnings in the past year.
EMEIS had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: EMEIS reported negative net income in multiple years.
EMEIS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of -3.07%, EMEIS is not doing good in the industry: 86.67% of the companies in the same industry are doing better.
The Return On Equity of EMEIS (-23.89%) is worse than 83.33% of its industry peers.
EMEIS's Return On Invested Capital of 0.03% is on the low side compared to the rest of the industry. EMEIS is outperformed by 83.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.07% | ||
| ROE | -23.89% | ||
| ROIC | 0.03% |
ROA(3y)-7.04%
ROA(5y)-3.96%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
EMEIS has a Operating Margin of 0.08%. This is amonst the worse of the industry: EMEIS underperforms 83.33% of its industry peers.
In the last couple of years the Operating Margin of EMEIS has declined.
EMEIS does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.08% | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3Y-79.31%
OM growth 5Y-64.56%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EMEIS is destroying value.
The number of shares outstanding for EMEIS has been increased compared to 1 year ago.
EMEIS has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, EMEIS has a worse debt to assets ratio.
2.2 Solvency
EMEIS has an Altman-Z score of 0.60. This is a bad value and indicates that EMEIS is not financially healthy and even has some risk of bankruptcy.
EMEIS has a Altman-Z score of 0.60. This is in the lower half of the industry: EMEIS underperforms 76.67% of its industry peers.
EMEIS has a debt to FCF ratio of 51.23. This is a negative value and a sign of low solvency as EMEIS would need 51.23 years to pay back of all of its debts.
The Debt to FCF ratio of EMEIS (51.23) is worse than 83.33% of its industry peers.
A Debt/Equity ratio of 4.80 is on the high side and indicates that EMEIS has dependencies on debt financing.
EMEIS's Debt to Equity ratio of 4.80 is on the low side compared to the rest of the industry. EMEIS is outperformed by 76.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.8 | ||
| Debt/FCF | 51.23 | ||
| Altman-Z | 0.6 |
ROIC/WACC0.01
WACC4.72%
2.3 Liquidity
A Current Ratio of 0.62 indicates that EMEIS may have some problems paying its short term obligations.
EMEIS has a worse Current ratio (0.62) than 80.00% of its industry peers.
EMEIS has a Quick Ratio of 0.62. This is a bad value and indicates that EMEIS is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.62, EMEIS is doing worse than 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.62 | ||
| Quick Ratio | 0.62 |
3. Growth
3.1 Past
EMEIS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -142.36%.
EMEIS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.43%.
The Revenue has been growing by 8.55% on average over the past years. This is quite good.
EPS 1Y (TTM)-142.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-114.25%
Revenue 1Y (TTM)8.43%
Revenue growth 3Y9.45%
Revenue growth 5Y8.55%
Sales Q2Q%7.73%
3.2 Future
EMEIS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.56% yearly.
The Revenue is expected to grow by 5.22% on average over the next years.
EPS Next Y61.81%
EPS Next 2Y28.88%
EPS Next 3Y29.56%
EPS Next 5YN/A
Revenue Next Year5.29%
Revenue Next 2Y5.18%
Revenue Next 3Y5.22%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
EMEIS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year EMEIS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
EMEIS's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. EMEIS is cheaper than 70.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.43 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
EMEIS's earnings are expected to grow with 29.56% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.88%
EPS Next 3Y29.56%
5. Dividend
5.1 Amount
No dividends for EMEIS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EPA:EMEIS (6/6/2025, 7:00:00 PM)
10.19
-0.04 (-0.39%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners55.18%
Inst Owner ChangeN/A
Ins Owners0.81%
Ins Owner ChangeN/A
Market Cap1.65B
Analysts75.38
Price Target12.34 (21.1%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.25%
PT rev (3m)21%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-127.4%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.67%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.29 | ||
| P/FCF | 9.43 | ||
| P/OCF | 3.48 | ||
| P/B | 0.95 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-2.65
EYN/A
EPS(NY)-0.85
Fwd EYN/A
FCF(TTM)1.08
FCFY10.6%
OCF(TTM)2.92
OCFY28.69%
SpS34.91
BVpS10.68
TBVpS-7.69
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.07% | ||
| ROE | -23.89% | ||
| ROCE | 0.04% | ||
| ROIC | 0.03% | ||
| ROICexc | 0.03% | ||
| ROICexgc | 0.04% | ||
| OM | 0.08% | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | 3.1% |
ROA(3y)-7.04%
ROA(5y)-3.96%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-77.23%
ROICexcg growth 5Y-61.49%
ROICexc growth 3Y-76.08%
ROICexc growth 5Y-60.94%
OM growth 3Y-79.31%
OM growth 5Y-64.56%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.42
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.8 | ||
| Debt/FCF | 51.23 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 5.28% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.62 | ||
| Quick Ratio | 0.62 | ||
| Altman-Z | 0.6 |
F-Score4
WACC4.72%
ROIC/WACC0.01
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)5.82%
Cap/Sales(5y)13.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-142.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-114.25%
EPS Next Y61.81%
EPS Next 2Y28.88%
EPS Next 3Y29.56%
EPS Next 5YN/A
Revenue 1Y (TTM)8.43%
Revenue growth 3Y9.45%
Revenue growth 5Y8.55%
Sales Q2Q%7.73%
Revenue Next Year5.29%
Revenue Next 2Y5.18%
Revenue Next 3Y5.22%
Revenue Next 5YN/A
EBIT growth 1Y103.51%
EBIT growth 3Y-77.35%
EBIT growth 5Y-61.53%
EBIT Next Year10863.7%
EBIT Next 3Y422.27%
EBIT Next 5YN/A
FCF growth 1Y293.3%
FCF growth 3YN/A
FCF growth 5Y14.58%
OCF growth 1Y28.92%
OCF growth 3Y-14.44%
OCF growth 5Y-10.16%